| 摘要 |
A pharmaceutical composition comprising as an ingredient and source of vitamin B6 pyridoxal (PL) or a physiologically compatible acid addition salt or complex of PL which in vivo rapidly release PL. Preferred further ingredients include a physiologically compatible antioxidant, e.g. ascorbic acid, glutamate, riboflavine and physiologically compatible salts of zinc and magnesium. The composition is used in humans and vetterinary medicine for the treatment or prophylaxis of one or more of the following: (i) physiological shock (ii) myocardial infarction (iii) clinical conditions associated with elevated blood biogenic polyamine levels and depressed blood B6 activity (iv) depressed blood B6 activity associated with the treatment of diseases or clinical conditions involving the use of B6-antagonistic drugs which cause or contribute to cellular B6 depletion and/or polyamine elevation. Preferred forms of administration are parenteral, e.g. by infusion. |
